For the last couple of months, retail drug store shares have sold off heavily, as investors responded negatively to the steady stream of data coming from the group, showing a universally-weak sales trend.

In these tough times, consumers have not only cut their purchases of such small luxuries as cosmetics and confections, but also necessities like prescriptions. But there are now signs that the sales and profit picture for the group could be on the mend.

IN PICTURES: 10 Insurance Tips For Homeowners

CVS Reports Surprise Sales Jump
Recently, industry leader CVS Caremark (NYSE:CVS) saw its shares jump by more than 5%, following the release of quarterly results that showed a decent uptick in same-store-sales. While earnings per share for the quarter of 79 cents roughly matched expectations, same-store-sales, a key measure of retail health, rose a healthy 4.9%. (learn more about how to analyze retail stocks, see Analyzing Retail Stocks.)

Also boosting investor confidence was evidence that problems with the company's prescription drug benefits administration business may have been resolved. The unit earlier lost two major clients, accounting for about $4.8 billion in sales, but new client adds appeared to have offset much of these losses.

Negative Sales Trend Industry Wide
CVS's improvement in same-store sales stands in stark contrast to the disappointing sales trend recently reported by rival Walgreens (NYSE:WAG), which reported a 1.1% drop in the same metric against analyst's expectations of a 2.2% gain. It was second straight month that Walgreens' same-store sales have been in the negative column. Smaller pharmacy chain Rite Aid (NYSE:RAD) also hasn't been immune to the negative sales trend, recently reporting its seventh consecutive negative sales month in December.

Pharmacies Now Adopting Low Cost Prescription Plans
In both these cases, prescription sales were down, in addition to general merchandise. And that's a big problem in the pharmacy business, since many shoppers in to fill a prescription tend to buy other items before they leave the store.

But CVS seems to have found the solution to turning this trend around. The company saw its prescription sales jump after it adopted a 90-day prescription sales plan. Such bulk buying schemes are a lower cost option for many consumers and covers many generic drugs. It's a strategy that Wal-Mart (NYSE:WMT) has had in place since 2008, and one that the pharmacies have recently picked-up on. Walgreens launched its own scheme last year.

Generic Drug Windfall Ahead
Any loss in profitability resulting from this shift in prescription marketing strategy will likely be more than made up for by pending developments with generic drugs. Large numbers of branded drugs are now poised to be replaced by generics, offering pharmacies dramatically higher margins. While competition will ultimately determine how high these margins can go, most analysts covering the sector see a huge profit windfall ahead.

The Bottom Line
Matching Wal-Mart's low-cost prescription sales strategy appears to paid off for CVS and will probably stem the negative sales tide for the rest of the players in the retail drug sector. That should be enough to swing market sentiment back into the bullish camp for this group.

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

Related Articles
  1. Investing News

    What You Can Learn from Carl Icahn's Mistakes

    Carl Icahn has been a stellar performer in the investment world for decades, but following his lead these days could be dangerous.
  2. Stock Analysis

    Analyzing Altria's Return on Equity (ROE) (MO)

    Learn about Altria Group's return on equity (ROE) and analyze net profit margin, asset turnover and financial leverage to determine what is causing its high ROE.
  3. Investing News

    Icahn's Bet on Cheniere Energy: Should You Follow?

    Investing legend Carl Icahn continues to lose money on Cheniere Energy, but he's increasing his stake. Should you follow his lead?
  4. Stock Analysis

    Analyzing Google's Return on Equity (ROE) (GOOGL)

    Learn about Alphabet's return on equity. How has its ROE changed over time, how does it compare to its peers and what factors are driving ROE for the company?
  5. Investing News

    Is Buffett's Bet on Oil Right for You? (XOM, PSX)

    Oil stocks are getting trounced, but Warren Buffett still likes one of them. Should you follow the leader?
  6. Investing News

    Chipotle Served with Criminal Probe

    Chipotle's beat muted expectations and got a clear bill from the CDC, but it now appears that an investigation into its E.coli breakout has expanded.
  7. Stock Analysis

    Analyzing Sprint Corp's Return on Equity (ROE) (S)

    Learn about Sprint's return on equity. Find out why its ROE is negative and how asset turnover and financial leverage impact ROE relative to Sprint's peers.
  8. Stock Analysis

    Why Alphabet is the Best of the 'FANGs' for 2016

    Alphabet just impressed the street, but is it the best FANG stock?
  9. Investing News

    A 2016 Outlook: What January 2009 Can Teach Us

    January 2009 and January 2016 were similar from an investment standpoint, but from a forward-looking perspective, they were very different.
  10. Mutual Funds & ETFs

    3 Vanguard Equity Fund Underperformers

    Discover three funds from Vanguard Group that consistently underperform their indexes. Learn how consistent most Vanguard low-fee funds are at matching their indexes.
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>
Trading Center